99 related articles for article (PubMed ID: 3707893)
21. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
22. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
[TBL] [Abstract][Full Text] [Related]
23. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women.
Halverstadt A; Phares DA; Wilund KR; Goldberg AP; Hagberg JM
Metabolism; 2007 Apr; 56(4):444-50. PubMed ID: 17378998
[TBL] [Abstract][Full Text] [Related]
24. High-density lipoprotein particle uptake and selective uptake of high-density lipoprotein-associated cholesteryl esters by J774 macrophages.
Rinninger F; Greten H
Biochim Biophys Acta; 1990 Apr; 1043(3):318-26. PubMed ID: 2157492
[TBL] [Abstract][Full Text] [Related]
25. Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment.
Carr SS; Hooper AJ; Sullivan DR; Burnett JR
Pathology; 2019 Feb; 51(2):148-154. PubMed ID: 30595507
[TBL] [Abstract][Full Text] [Related]
26. Influence of cholesterol on bilayers of ester- and ether-linked phospholipids. Permeability and 13C-nuclear magnetic resonance measurements.
Bittman R; Clejan S; Lund-Katz S; Phillips MC
Biochim Biophys Acta; 1984 May; 772(2):117-26. PubMed ID: 6722139
[TBL] [Abstract][Full Text] [Related]
27. Degradation of low density lipoprotein cholesterol esters by lysosomal lipase in vitro. Effect of core physical state and basis of species selectivity.
Lusa S; Somerharju P
Biochim Biophys Acta; 1998 Jan; 1389(2):112-22. PubMed ID: 9461252
[TBL] [Abstract][Full Text] [Related]
28. Analyzing of high-density lipoprotein subfractions and low-density lipoprotein subfractions in human serum with anion-exchange chromatography.
Hirowatari Y; Tsunoda Y; Ogura Y; Homma Y
Atherosclerosis; 2009 Jun; 204(2):e52-7. PubMed ID: 19091316
[TBL] [Abstract][Full Text] [Related]
29. Microemulsions of cholesteryl oleate and dimyristoylphosphatidylcholine: a model for cholesteryl ester rich very low density lipoproteins.
Mims MP; Guyton JR; Morrisett JD
Biochemistry; 1986 Jan; 25(2):474-83. PubMed ID: 3456798
[TBL] [Abstract][Full Text] [Related]
30. 13C-NMR spectroscopy of human serum high density lipoprotein enriched with labelled phospholipids.
Stoffel W; Salm K; Tunggal B
Hoppe Seylers Z Physiol Chem; 1979 Apr; 360(4):523-8. PubMed ID: 220173
[TBL] [Abstract][Full Text] [Related]
31. Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.
Bays H; Giezek H; McKenney JM; O'Neill EA; Tershakovec AM
Metab Syndr Relat Disord; 2012 Aug; 10(4):260-6. PubMed ID: 22400810
[TBL] [Abstract][Full Text] [Related]
32. A fluorescent sterol probe study of human serum low-density lipoproteins.
Smutzer G
Biochim Biophys Acta; 1988 Feb; 958(3):323-33. PubMed ID: 3342245
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing interaction of human plasma low-density lipoproteins with discoidal complexes of apolipoprotein A-I and phosphatidylcholine.
Shahrokh Z; Nichols AV
Biochim Biophys Acta; 1986 Sep; 878(2):152-8. PubMed ID: 3092865
[TBL] [Abstract][Full Text] [Related]
34. Central role of high density lipoprotein in plasma free cholesterol metabolism.
Schwartz CC; Vlahcevic ZR; Berman M; Meadows JG; Nisman RM; Swell L
J Clin Invest; 1982 Jul; 70(1):105-16. PubMed ID: 6953075
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction.
Lund-Katz S; Laplaud PM; Phillips MC; Chapman MJ
Biochemistry; 1998 Sep; 37(37):12867-74. PubMed ID: 9737865
[TBL] [Abstract][Full Text] [Related]
36. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
37. Relationship of apolipoprotein B levels to the number of risk factors for metabolic syndrome.
Clarenbach JJ; Grundy SM; Palacio N; Vega GL
J Investig Med; 2007 Jul; 55(5):237-47. PubMed ID: 17850735
[TBL] [Abstract][Full Text] [Related]
38. Multicompartmental analysis of cholesterol metabolism in man. Quantitative kinetic evaluation of precursor sources and turnover of high density lipoprotein cholesterol esters.
Schwartz CC; Berman M; Vlahcevic ZR; Swell L
J Clin Invest; 1982 Oct; 70(4):863-76. PubMed ID: 7119117
[TBL] [Abstract][Full Text] [Related]
39. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
[TBL] [Abstract][Full Text] [Related]
40. Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.
Soedamah-Muthu SS; Chang YF; Otvos J; Evans RW; Orchard TJ;
Diabetologia; 2003 May; 46(5):674-82. PubMed ID: 12743701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
